Replimune Group, Inc.
REPLNASDAQHealthcare● Active
$8.80
$-0.67(-7.07%)
Market Cap$726647304
P/E Ratio—
52W High$13.24
52W Low$1.5
Replimune Group, Inc. (REPL) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · REPL · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-03 | 2024-03 | 2023-03 | 2022-03 | 2021-03 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Cost of Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Profit | $0.00B | $0.00B | $0.00B | ($0.00B) | ($0.00B) |
| Gross Margin %(computed) | — | — | — | — | — |
| Operating Expenses | |||||
| R&D Expenses | $0.19B | $0.17B | $0.13B | $0.08B | $0.06B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $0.26B | $0.23B | $0.18B | $0.12B | $0.08B |
| Operating Income | ($0.26B) | ($0.23B) | ($0.18B) | ($0.12B) | ($0.08B) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $0.02B | $0.02B | $0.01B | $0.00B | $0.00B |
| Interest Expense | $0.01B | $0.01B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.25B) | ($0.22B) | ($0.17B) | ($0.12B) | ($0.08B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | ($0.00B) | ($0.00B) |
| Net Income | ($0.25B) | ($0.22B) | ($0.17B) | ($0.12B) | ($0.08B) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-3.07 | $-3.24 | $-2.99 | $-2.26 | $-1.75 |
| Wtd Avg Shares | 0.08B | 0.07B | 0.06B | 0.05B | 0.05B |
| EBITDA | ($0.25B) | ($0.23B) | ($0.17B) | ($0.11B) | ($0.08B) |
| EBITDA Margin %(computed) | — | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Replimune Group, Inc. data
About Replimune Group, Inc. (REPL) Income Statement
Replimune Group, Inc. (REPL) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, REPL reported revenue of $0.00B, gross profit of $0.00B (gross margin —), and net income of ($0.25B) — a net profit margin of —.
Frequently asked questions
REPL · 4 questionsReplimune Group, Inc. (REPL) reported revenue of $0.00B for 2025, down —% year-over-year.
REPL revenueREPL salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08